Charlotte Schubert / GeekWire
Funding news: Cyrus lands $18M and buys startup developing COVID-19 therapeutic; Spare Labs snags $1 – The news: Seattle-based protein engineering company Cyrus Biotechnology has raised $18 million and acquired Orthogonal Biologics, a spinout from the University of Illinois at Urbana Champaign, which is developing a COVID-19 therapeutic. Combining forces: Cyrus has built up a software-and-screening platform to re-design natural proteins, leveraging tech spun out of …
